
vchal | BigStock.com
An mRNA-based vaccine against African swine fever (ASF) could be more effective — and potentially cheaper — than the conventional vaccines entering the market, according to a research group at the Massachusetts Institute of Technology (MIT).
The group has identified targets on the virus that could be used to create an mRNA vaccine, a technology that uses genetic components of the targeted virus, rather than the whole virus itself, to trigger immune defenses.

















